Key Insights

Highlights

Success Rate

77% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

13.2%

7 terminated out of 53 trials

Success Rate

77.4%

-9.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

8 of 24 completed with results

Key Signals

8 with results77% success

Data Visualizations

Phase Distribution

41Total
Not Applicable (11)
Early P 1 (1)
P 1 (16)
P 2 (13)

Trial Status

Completed24
Recruiting10
Terminated7
Unknown7
Active Not Recruiting3
Withdrawn1

Trial Success Rate

77.4%

Benchmark: 86.6%

Based on 24 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT05550948Not ApplicableCompletedPrimary

Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer

NCT06131801Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT04601584Phase 1Terminated

GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL

NCT00863148Phase 2Completed

Allogeneic Stem Cell Transplant With Clofarabine, Busulfan and Antithymocyte Globulin (ATG) for Adult Patients With High-risk Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) or Acute Lymphoblastic Leukemia (ALL)

NCT03739502Phase 2Active Not Recruiting

A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

NCT03571321Phase 1Recruiting

Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia

NCT02315612Phase 1Completed

Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies

NCT06047886Phase 1Recruiting

UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy

NCT07516353Not ApplicableNot Yet Recruiting

my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

NCT04644016Phase 2Recruiting

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

NCT02990572RecruitingPrimary

Amish/Mennonite Research Contact Registry

NCT05016947Phase 1Active Not Recruiting

Venetoclax Plus Inotuzumab for B-ALL

NCT07252336Phase 2RecruitingPrimary

A Multicenter Study of CAR-T Cells in Primary Ph+All

NCT05940961Phase 2RecruitingPrimary

Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL

NCT06244147CompletedPrimary

Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults

NCT00776373Phase 1TerminatedPrimary

Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies

NCT06976736Recruiting

A Long Term Follow-up Study of TScan TCR-T Products

NCT04473911Phase 1Completed

Haplo Peripheral Blood Sct In GVHD Prevention

NCT01532635Phase 2Terminated

A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

NCT03114553CompletedPrimary

Family History in a Singaporean Healthy Population

Scroll to load more

Research Network

Activity Timeline